← FDA Drug Approvals (Drugs@FDA)

BRIVARACETAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MICRO LABS · Approved 2026-02-23

Drug application

FDA Application #

ANDA214880

Application type

Abbreviated New Drug Application (Generic)

Brand name

BRIVARACETAM

Generic name

BRIVARACETAM

Active ingredients

BRIVARACETAM

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

MICRO LABS

Manufacturer

Micro Labs Limited

First approval

2026-02-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown